Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
Shashen Maidong Decoction's Effects on Chronic Bronchitis: A Multi-Method Approach.
Wenchao Zhou1,2, Yaqin Hu2, Yun Qiu1,2
1TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Materia Medica Research Institute, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China.
Shashen Maidong Decoction (SSMDD) reduces inflammation in chronic bronchitis (CB) by targeting Interleukin 6 (IL-6). Key compounds quercetin and kaempferol significantly lower IL-6 levels, validating its therapeutic potential.
Area of Science:
- Pharmacology
- Traditional Chinese Medicine
- Immunology
Background:
- Shashen Maidong Decoction (SSMDD) is a traditional Chinese medicine (TCM) formula.
- Chronic bronchitis (CB) is a significant respiratory condition.
- Interleukin 6 (IL-6) is a key inflammatory mediator in CB.
Purpose of the Study:
- To elucidate the anti-inflammatory mechanism of SSMDD in chronic bronchitis (CB).
- To identify active components of SSMDD and their targets.
- To investigate the impact of SSMDD on Interleukin 6 (IL-6) expression.
Main Methods:
- Network pharmacology to predict active compounds and targets.
- Molecular docking to assess binding affinity.
- Transcriptomic analysis, ELISA, and Western blot for mechanism validation.
Main Results:
- Quercetin and kaempferol identified as key active components targeting IL-6.
- SSMDD demonstrated regulation of inflammation-related pathways.
- Significant reduction in IL-6 levels (55% for quercetin, 36% for kaempferol) and protein expression (33% for quercetin, 25% for kaempferol) observed.
Conclusions:
- SSMDD exerts anti-inflammatory effects in CB by targeting IL-6.
- Provides mechanistic insights into SSMDD's therapeutic action.
- Suggests potential for SSMDD in treating other inflammatory diseases.
More Related Videos
05:56A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...